Subscribers,

Our recent winner, JUPW, just released breaking news, check it out here...

Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science

• Assets include issued patents, patent applications, products, clinical trial results, licensing agreements
• Applied Biology generated approximately $8 million in revenues and $3 million in EBITDA in 2021 (unaudited)
• Regulatory expertise with US FDA, EMA, KFDA (Korea), PMDA (Japan), ANVISA (Brazil), CFDA (China)

Jun 21, 2022 (ACCESSWIRE via COMTEX) -- JUPITER, FL / ACCESSWIRE / June 21, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced the acquisition of 100% of the assets of Applied Biology, Inc. a leading biotechnology company specializing in hair and skin science, for up to 4 million shares of Jupiter Wellness stock deliverable upon completion of certain milestones.

Applied Biology is a developer of breakthrough drugs and medical devices for the treatment of skin and hair disorders. Led by the foremost thought leaders in their fields, the company's R&D pipeline of novel pharmaceuticals is focused on hair and skin conditions as well as women's health and COVID-19. They have several products in development from pre-clinical to advanced stages. Applied Biology has provided clinical research, IP development, and regulatory services to healthcare companies worldwide through a global network of clinical sites to advance its proprietary therapies and products.

Before the acquisition, Jupiter Wellness and Applied Biology had well-established and ongoing collaborations including Jupiter Wellness's exclusive license for Applied Biology's Photocil™ psoriasis treatment in the United States, as well as Applied Biology serving as the clinical research organization for several of Jupiter Wellness's proprietary cannabidiol dermatological treatment candidates.

Acquisition Highlights

• Expected to Accelerate Top and Bottom-line Growth: Jupiter Wellness expects Applied Biology's financial performance to at once contribute to Jupiter Wellness's financial results. With the potential of adding up to $8 million in revenues and $3 million in EBITDA on an annualized basis (based on 2021 unaudited financials)
   
• Acceleration and Expansion of Development Pipeline: The acquisition expands Jupiter Wellness's pipeline to additional dermatology drugs in various stages of clinical and preclinical development. Applied Biology brings the following portfolio:
  • Alopecia - pipeline for the treatment of traction alopecia, androgenetic alopecia, and chemotherapy-induced alopecia.
  • Psoriasis - A topical treatment for psoriasis to be launched in late 2022.
  • Women's Health - A novel treatment for female sexual dysfunction in the clinical stage was recently granted 2 patents
     
• Adds Exceptional Clinical, Regulatory Expertise, and Human Capital: Led by Prof. Andy Goren, Applied Biology's management team and medical board bring a deep expertise from concept through clinical development to commercialization, a key strategic asset for Jupiter with access to eight major dermatological hospitals around the world. Prof. Andy Goren will become Chief Medical Officer of Jupiter Wellness, and John McCoy PhD will become Vice-President of R&D.
   
• Commercialized Products:
  • Photocil - Jupiter Wellness gains worldwide rights to patented Photocil, a novel topical treatment for psoriasis, vitiligo, pruritis, and atopic dermatitis. Jupiter Wellness had previously licensed the exclusive rights to market Photocil in the U.S. where it plans to launch the product in Q4 2022. With the acquisition, Jupiter Wellness now owns all rights to Photocil which is approved and commercialized in Europe, Asia, and the Middle East.
  • Minoxidil Booster - Minoxidil Booster greatly improves the efficacy of minoxidil (from 30% to 60%+) by enhancing the generation of minoxidil sulfate, the active drug. Several licensing and distribution agreements for this product have been signed.
     
• Adds Robust IP Estate: Applied Biology's IP portfolio includes 35 patent applications and three issued U.S. patents for:
  • Photocil: Methods and Compositions for Administering a Specific Wavelength Phototherapy
  • COVID-19 and Respiratory Infection Treatment: Systems, Methods, and Kits for Diagnostics and Treatment of Viral Respiratory Infection
  • Women's Health: Treatment of Sexual Dysfunction

"Jupiter Wellness has enjoyed a highly productive and long-term business relationship with Applied Biology and we are excited to welcome Prof. Andy Goren and his talented team to Jupiter. This highly synergistic asset purchase leverages Jupiter Wellness's current clinical development pipeline and adds tremendous clinical, IP, and regulatory expertise, access to patients and clinical sites worldwide, and positions us with meaningful growing revenues and EBITDA," said Jupiter Wellness CEO Brian John.

Source: https://www.marketwatch.com/press-release/jupiter-wellness-acquires-the-assets-of-applied-biology-inc-a-leading-biotechnology-company-specializing-in-hair-and-skin-science-2022-06-21?mod=mw_quote_news_seemore

 
Let's dive in because we don't have a moment to spare.
Here's some figures I want you to soak in (1):

• In 2018, the Eczema Treatment Market was worth approximately $7.7Bn
• In 2019, the Burn Ointment Market was approximately $814Mn
• In 2017, Global Herpes Simplex Virus Treatment Market was set to reach $4.8Bn
• And, in 2019, the Skin Cancer Treatment Market hit approximately $8.19Bn

So why is this important? Let's just say I've come across a company that is bringing a "Green Wave" approach to combating these illnesses/diseases/problems.

That's why for today's opening bell, there is only one profile to have on your radar:
Jupiter Wellness, Inc.is a leading developer of canna-bid-iol ("CB") based medical therapeutics and wellness products. The Company's clinical pipeline of prescription CB-enhanced skin care therapeutics address indications including eczema, burns, herpes cold sores, and skin cancer.

Jupiter generates revenues from a growing line of proprietary over-the-counter skincare products including its flagship CaniSun™ sunscreen and other wellness brands sold through its robust distribution platform.
 
Here's a breakdown of how JUPW plans to become an industry leader:

• CB-based topical therapeutics targeting multiple Bn-dollar treatment markets
• Strategy to launch over-the-counter (OTC) version of products leading up to FDA-approved prescription therapeutics
• Building a portfolio of proprietary, patent-pending skincare products including flagship CaniSun™ brand of sunscreens
• Generating high-margin revenues through OTC and wellness product sales
• In-creasing current cash flows through acquisition of new wellness brands and ecommerce distribution platforms
• Management team with expertise and performance track record in pharma clinical trials and OTC wellness market

-----






No. 1 Potential JUPW Catalyst - Low Float

According to Yahoo Finance, JUPW has a small float.

The website reports this profile to have 12.9Mn shares in its float.

Why is that important? It's important on one crucial level. Volatility.

With so few shares available for trading, potential driver indicators can send shares heading vertical in the short-term.

-----

No. 2 Potential JUPW Catalyst - History Of Short Term Breakouts

Check out JUPW's chart:



On multiple occasions, this low float profile has demonstrated the ability to break out in epic fashion.

Here's a handful of times over the past six months to take note of:

1. JUPW surged from around $0.60 all the way up to around $1.35 in one month - a 125% gain
2. JUPE bounced big from around $0.90 to $1.50 in just a few weeks - a solid 67% gai

Now, JUPW has hit long term support - exactly where it was in January before it exploded for triple digit gains.

-----

No. 3 Potential JUPW Catalyst - Key Personnel Appointment

Paul Jones Appointed as Senior Project Manager at Jupiter Wellness

JUPITER, FL / ACCESSWIRE / June 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Paul Jones has joined Jupiter Wellness as Senior Project Manager.

Paul joins Jupiter Wellness with over 20 years of experience building and directing operations, implementing improvements and overseeing projects in a wide range of industries.

Most recently he was Project Manager in an Investment and Management Company with operations in South Florida and Italy. He was responsible for initiating projects in the US and Italy, managing costs, timelines, and project performance from initiation through completion.

From 2004 - 2011 he was part of the project management team at Ferrari headquarters in Maranello, Italy where he headed the Design Production Team for Ferrari and Maserati.

"We are extremely excited to add someone of Paul's caliber to the Jupiter Wellness Team. With our rapid growth, he will be an integral part of our team managing and maximizing our product pipeline both for the consumer products and new products in in scientific development ." Stated Dr. Glynn Wilson, CSO and Chairman.

Read the full article here.

-----

No. 4 Potential JUPW Catalyst - Publishing Of Clinical Study Results

Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual Revenue & EBITDA Contribution to Jupiter

IN A BID TO EXPAND JUPITER WELLNESS'S RESEARCH CAPABILITIES AND ENTER THE LUCRATIVE CRO BUSINESS, JUPITER WELLNESS ACQUIRED THE ASSETS OF ASCENT CLINICAL RESEARCH

JUPITER, FL / ACCESSWIRE / April 27, 2022 /Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it has concluded an Asset Purchase Agreement with Ascent Clinical Research, Inc. through which it has acquired certain clinical assets including clinical trial research contracts worth $3 million in annual revenues for a purchase price of 5% royalties on future net revenues generated by the assets.

"This strategic asset purchase agreement adds immediate revenues to Jupiter in Q2 2022 and contributes positively towards EBITDA with no upfront cash or stock acquisition cost to our company. The acquired contracts and related assets enhance Jupiter's position as a research and development powerhouse while allowing us to enter the lucrative clinical research organization business," stated Jupiter CEO Brian John.

Read the full article here.

-----

So, JUPW has plenty of short and long term catalysts that could see tremendous upside. Get JUPW on your screen immediately and be ready for the opening bell.



All the best.

SmallCapMomo.com

picks@smallcapmomo.com

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.